SEC Form 4 · accession 0001077183-18-000151
NEOGENOMICS INC · NEO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
A later amendment supersedes this filing — read the amendment. The figures below are kept as originally reported (version chain, not an overwrite).
Reporting owner
Kevin C Johnson
Director
Period of report
Dec 21, 2018
Accepted (ET)
Dec 26, 2018 · 7:08 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001077183
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Dec 21, 2018 | P | 26,000 | $11.60 | A | 103,866 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $4.78 | holding | — | — | — | May 6, 2016 | May 6, 2020 | Common Stock | 6,667 | 6,667 | D |
| Stock Option (Right to Buy)F2 | $9.11 | holding | — | — | — | Jul 28, 2017 | Jul 28, 2021 | Common Stock | 8,333 | 8,333 | D |
| Stock Option (Right to Buy)F3 | $7.27 | holding | — | — | — | May 25, 2018 | May 25, 2022 | Common Stock | 10,000 | 10,000 | D |
| Stock Option (Right to Buy)F4 | $11.60 | holding | — | — | — | Jun 1, 2019 | Jun 1, 2023 | Common Stock | 3,017 | 3,017 | D |
Explanation of responses
- F1On May 6, 2015 Mr. Johnson was granted 10,000 stock options. The options vest ratably over the first three anniversary dates of the grant date.
- F2On July 28, 2016, Mr. Johnson was granted 8,333 stock options. The options vest ratably over the first three anniversary dates of the grant date.
- F3On May 25, 2017, Mr. Johnson was granted 10,000 stock options. The options vest ratably over the first three anniversary dates of the grant date.
- F4On June 1, 2018, Mr. Johnson was granted 3,017 stock options. These options vest on June 1, 2019.